Contineum Therapeutics, Inc. (CTNM)

11.50 -1.23 (-9.66%) USD  |  NASDAQ  |  Sep 29, 16:00
11.96 +0.46 (+4.00%) Pre-Market: 09:28
More

Contineum Therapeutics Max Drawdown (5Y)

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for CTNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to . Start Trial.
Date Value

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Cocrystal Pharma, Inc. 97.93%
CNBX Pharmaceuticals, Inc. 100.0%
GB Sciences, Inc. 100.00%
Arvinas, Inc. 94.37%
Fulcrum Therapeutics, Inc. 92.70%